MarketCapTrends
BIO
Bio-Rad Laboratories Inc. (BIO)
NYSE · Healthcare

Bio-Rad Laboratories Inc. Shareholder Equity 2008–2025

Bio-Rad Laboratories Inc. annual/quarterly shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Bio-Rad Laboratories Inc. shareholder equity for the quarter ending December 31, 2025 were 7.45B, a 13.46% increase year-over-year.
  • Bio-Rad Laboratories Inc. shareholder equity for 2025 were 7.45B, a 13.46% increase from 2024.
  • Bio-Rad Laboratories Inc. shareholder equity for 2024 were 6.57B, a 24.85% decrease from 2023.
  • Bio-Rad Laboratories Inc. shareholder equity for 2023 were 8.74B, a 9.09% decrease from 2022.
  • Bio-Rad Laboratories Inc. shareholder equity for 2022 were 9.62B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Bio-Rad Laboratories Inc. Annual Shareholder Equity (Millions of US $)
2025$7,454
2024$6,569
2023$8,741
2022$9,615
2021$13,685
2020$9,890
2019$5,757
2018$4,020
2017$2,930
2016$2,579
2015$2,485
2014$2,184
2013$2,187
2012$2,015
2011$1,744
Bio-Rad Laboratories Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$7,454
2024-12-31$6,569
2023-12-31$8,741
2022-12-31$9,615
2021-12-31$13,685
2020-12-31$9,890
2019-12-31$5,757
2018-12-31$4,020
2017-12-31$2,930
2016-12-31$2,579
2015-12-31$2,485
2014-12-31$2,184
2013-12-31$2,187
2012-12-31$2,015
2011-12-31$1,744
2010-12-31$1,537
2009-12-31$1,260

Bio-Rad Laboratories Inc. Shareholder Equity — FAQ

Bio-Rad Laboratories Inc. (BIO) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BIO's shareholder equity history?

The chart and table above show Bio-Rad Laboratories Inc.'s shareholder equity by year and by quarter, including the growth rate.